The cancer patient's perspective of COVID-19-induced distress-A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic.
Karin A KoinigChristoph ArnoldJens LehmannJohannes M GiesingerStefan KöckWolfgang WillenbacherRoman WegerBernhard HolznerUte GanswindtDominik WolfReinhard StauderPublished in: Cancer medicine (2021)
Particularly younger and female cancer patients, and those with impaired emotional functioning are distressed by COVID-19. During the first COVID-19 lockdown, cancer patients remained predominantly resilient. This analysis highlights the need to mitigate distress situations in vulnerable patients and thereby enhance resilience during pandemics.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- respiratory syndrome coronavirus
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- papillary thyroid
- case report
- climate change
- squamous cell carcinoma
- high glucose
- depressive symptoms
- social support
- oxidative stress
- risk factors
- drug induced
- stress induced